Eric Halioua, President & CEO at PDC*line Pharma Shares Insights on the Results from P-I/II Trial with PDC*lung01
PharmaShots
JUNE 1, 2023
These new results reinforce our differentiating data package for PDC*lung01. It is irradiated to stop its proliferation while keeping its functionality and can be stored in liquid nitrogen over the long term. Eric Halioua: Yes, we are working on other indications such as Head & Neck and personalized neoantigens-based vaccines.
40 
Let's personalize your content